Gardnerella vaginalis is the primary bacterium behind bacterial vaginosis (BV), and treatment typically involves a course of antibiotics lasting five to seven days. The standard options are effective for most people, but recurrence is common, with over 50% of cases returning within three months. Understanding why it comes back and what you can do beyond antibiotics makes a real difference in long-term outcomes.
Standard Antibiotic Treatments
The CDC recommends three first-line options, all considered equally effective:
- Oral metronidazole: 500 mg taken twice daily for 7 days
- Metronidazole gel (0.75%): applied vaginally once daily for 5 days
- Clindamycin cream (2%): applied vaginally at bedtime for 7 days
Your provider will help you choose between oral and vaginal options based on your preferences and history. The oral route treats the entire body but can cause nausea and a metallic taste. The vaginal options tend to have fewer side effects since the medication stays localized. Both approaches produce clinical cure rates around 77% to 79% at the four-week mark.
A single-dose alternative also exists. Secnidazole is a 2-gram oral granule taken just once, and clinical trials show it performs comparably to the seven-day metronidazole course, with about a 77% clinical cure rate at 28 days. It’s a practical choice if sticking to a week-long regimen feels difficult.
Why Gardnerella Keeps Coming Back
The reason BV recurs so often comes down to biofilms. Gardnerella builds protective communities of bacteria that coat the vaginal lining and shield themselves from antibiotics. Research published in Frontiers in Microbiology found that neither metronidazole nor clindamycin can effectively eradicate these biofilms. The bacteria within a biofilm are significantly more resistant to antibiotics than the same bacteria floating freely, which is why symptoms clear up during treatment but return weeks later. The biofilm persists, allowing Gardnerella to repopulate once you stop the medication.
There are currently no drugs in clinical use that specifically target these biofilms, which is why combination strategies and prevention matter so much.
Treating Your Partner Reduces Recurrence
One of the most significant recent findings in BV treatment is that treating male sexual partners cuts recurrence nearly in half. A landmark trial published in the New England Journal of Medicine was actually stopped early by its safety board because the results were so clear: continuing to withhold partner treatment was considered inferior care.
In the trial, women whose male partners received both oral metronidazole and topical clindamycin cream (applied to penile skin) for seven days had a 35% recurrence rate at 12 weeks. Women whose partners went untreated had a 63% recurrence rate. That’s a dramatic difference. Recurrence rates were lowest when male partners closely followed the full treatment course.
This challenges the long-held assumption that BV isn’t sexually transmitted. The evidence now shows that BV-associated bacteria are exchanged between partners, and treating only one person leaves a reservoir of Gardnerella that reinfects you. If you have a regular male partner and you’re dealing with recurring BV, asking your provider about concurrent partner treatment is one of the most effective steps you can take.
Boric Acid as an Add-On Therapy
Intravaginal boric acid has gained attention as a supplemental treatment, particularly for recurrent BV. The approach typically involves completing a standard antibiotic course first, then using 600 mg boric acid suppositories daily for 21 days, followed by twice-weekly metronidazole gel as ongoing maintenance. This layered protocol is recommended by the CDC for recurrent cases.
In clinical practice, most women (about 74%) start with a “induction” phase of daily boric acid for 7 to 14 days before transitioning to a maintenance schedule. Satisfaction rates are relatively high at around 77%, though women who skipped the initial antibiotic treatment and used boric acid alone were the least satisfied. The takeaway: boric acid works best as a follow-up to antibiotics, not a replacement for them.
Restoring Healthy Vaginal Bacteria
A healthy vagina is dominated by Lactobacillus bacteria, which produce lactic acid and keep the pH low enough to suppress Gardnerella growth. BV disrupts this balance, and antibiotics alone don’t restore it. That’s where targeted probiotics come in.
A randomized trial published in the New England Journal of Medicine tested a vaginal probiotic containing a specific strain of Lactobacillus crispatus (called CTV-05) used after completing metronidazole gel treatment. Women who used this probiotic had significantly fewer BV recurrences at 12 weeks compared to placebo. The strain was still detectable in nearly 80% of participants at week 12 and about 50% at week 24, suggesting it genuinely colonizes the vagina rather than passing through.
Not all probiotics are the same. Over-the-counter vaginal and oral probiotics vary widely in strains and quality. The strongest clinical evidence is for L. crispatus applied vaginally after antibiotic treatment. Generic “women’s health” probiotics from the supplement aisle may contain entirely different species with little evidence behind them for BV specifically.
Hygiene Habits That Help and Hurt
Vaginal douching has no confirmed health benefits and consistently increases BV risk by disrupting the natural flora and undermining your body’s immune defenses. It’s also linked to higher rates of pelvic inflammatory disease and sexually transmitted infections. If you’re douching to manage odor from BV, treating the underlying infection is far more effective.
External vulvar cleansing with a mild, pH-balanced wash is a different story. Some evidence suggests that lactic acid-based intimate washes used externally may help support the vulvovaginal environment after BV treatment. These products aren’t treatments on their own, but they avoid the pH disruption caused by regular soap or fragranced body washes. The key distinction is external use only. Nothing should be introduced inside the vaginal canal for cleaning purposes.
Other practical habits that support recovery and prevention: wearing breathable cotton underwear, avoiding scented pads or tampons, and changing out of wet swimwear or workout clothes promptly. These won’t cure an active infection, but they help maintain the acidic environment that keeps Gardnerella in check.
Pregnancy and Gardnerella
BV during pregnancy has been associated with an increased risk of preterm birth. Some evidence suggests that treating BV before 20 weeks of gestation may reduce this risk, though the data isn’t definitive. If you’re pregnant and experiencing symptoms like unusual discharge or a fishy odor, getting tested and treated early is reasonable. Your provider will select an antibiotic with an appropriate safety profile for pregnancy.
Putting a Treatment Plan Together
For a first episode of BV, a standard antibiotic course is usually enough. Complete the full course even if symptoms resolve early, since stopping prematurely increases the chance the biofilm survives.
For recurrent BV (three or more episodes in a year), the most effective strategy layers multiple approaches: complete a full antibiotic course, follow with boric acid suppositories for several weeks, use a maintenance antibiotic schedule, consider a vaginal Lactobacillus probiotic, and discuss concurrent treatment for your male partner. Each of these steps targets a different part of the problem, from killing active bacteria to disrupting biofilms to repopulating protective flora to eliminating the partner reservoir. Used together, they offer the best chance of breaking the cycle.